{"id":1061,"date":"2013-03-19T14:44:06","date_gmt":"2013-03-19T13:44:06","guid":{"rendered":"https:\/\/www.francecoag.org\/?post_type=publications_science&#038;p=1061"},"modified":"2025-03-19T14:53:51","modified_gmt":"2025-03-19T13:53:51","slug":"meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit","status":"publish","type":"publications_science","link":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/","title":{"rendered":"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit"},"content":{"rendered":"<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23333129\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/23333129\/<\/a><\/p>\n<header id=\"heading\" class=\"heading\">\n<div id=\"full-view-heading\" class=\"full-view\">\n<ul id=\"full-view-identifiers\" class=\"identifiers\">\n<li><span class=\"identifier pubmed\"> <span class=\"id-label\"> PMID: <\/span> <strong class=\"current-id\" title=\"PubMed ID\">23333129<\/strong> <\/span><\/li>\n<li><span class=\"identifier doi\"> <span class=\"id-label\"> DOI: <\/span> <a class=\"id-link\" href=\"https:\/\/doi.org\/10.1016\/j.jpeds.2012.11.080\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\"> 10.1016\/j.jpeds.2012.11.080 <\/a> <\/span><\/li>\n<\/ul>\n<\/div>\n<\/header>\n<div id=\"abstract\" class=\"abstract\">\n<h2 class=\"title\">Abstract<\/h2>\n<div id=\"eng-abstract\" class=\"abstract-content selected\">\n<p><strong class=\"sub-title\"> Objectives: <\/strong> To evaluate the impact of the 2002 guidelines on the current status of prophylaxis in French children with severe hemophilia A or B.<\/p>\n<p><strong class=\"sub-title\"> Study design: <\/strong> Clinical information was captured, in a prospective way, using FranceCoag Network. We retrospectively studied 291 patients with severe (&lt;1 IU\/dL) hemophilia A and B, with no history of inhibitors.<\/p>\n<p><strong class=\"sub-title\"> Results: <\/strong> Our results demonstrate that the availability of national medical guidelines has improved clinical practice in France. In the past decade, the proportion of children with severe hemophilia undergoing prophylaxis has shown a significant 2- to 3-fold increase: \u223c80% of these children&gt;3 years of age are now receiving prophylaxis. In severe hemophilia A and B, the age at which prophylaxis commences has significantly decreased: 4.0 and 6.1 years for the period 1996-1999 as opposed to 1.8 and 1.4 years for the period 2004-2007 (P=.0001).<\/p>\n<p><strong class=\"sub-title\"> Conclusions: <\/strong> Long-term clinical and physical evaluations of patients will be necessary to establish the benefits of this increase in prophylactic treatment on the prevention of hemophilic arthropathy.<\/p>\n<\/div>\n<\/div>\n<p id=\"copyright\" class=\"copyright\">Copyright \u00a9 2013 Mosby, Inc. All rights reserved.<\/p>\n","protected":false},"parent":0,"template":"","keyword":[],"class_list":["post-1061","publications_science","type-publications_science","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit - FranceCoag<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit - FranceCoag\" \/>\n<meta property=\"og:description\" content=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23333129\/ PMID: 23333129 DOI: 10.1016\/j.jpeds.2012.11.080 Abstract Objectives: To evaluate the impact of the 2002 guidelines on the current status of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/\" \/>\n<meta property=\"og:site_name\" content=\"FranceCoag\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-19T13:53:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/publications_science\\\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\\\/\",\"url\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/publications_science\\\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\\\/\",\"name\":\"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit - FranceCoag\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/#website\"},\"datePublished\":\"2013-03-19T13:44:06+00:00\",\"dateModified\":\"2025-03-19T13:53:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/publications_science\\\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.francecoag.org\\\/en\\\/publications_science\\\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/publications_science\\\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications scientifiques\",\"item\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/publications_science\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/\",\"name\":\"FranceCoag\",\"description\":\"La cohorte FranceCoag accompagne plus de 10.000 patients atteints d\u2019une maladie h\u00e9morragique\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/#organization\",\"name\":\"FranceCoag\",\"url\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.francecoag.org\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/logo-france-COAG-1.png\",\"contentUrl\":\"https:\\\/\\\/www.francecoag.org\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/logo-france-COAG-1.png\",\"width\":600,\"height\":260,\"caption\":\"FranceCoag\"},\"image\":{\"@id\":\"https:\\\/\\\/www.francecoag.org\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit - FranceCoag","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/","og_locale":"en_US","og_type":"article","og_title":"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit - FranceCoag","og_description":"https:\/\/pubmed.ncbi.nlm.nih.gov\/23333129\/ PMID: 23333129 DOI: 10.1016\/j.jpeds.2012.11.080 Abstract Objectives: To evaluate the impact of the 2002 guidelines on the current status of [&hellip;]","og_url":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/","og_site_name":"FranceCoag","article_modified_time":"2025-03-19T13:53:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/","url":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/","name":"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit - FranceCoag","isPartOf":{"@id":"https:\/\/www.francecoag.org\/en\/#website"},"datePublished":"2013-03-19T13:44:06+00:00","dateModified":"2025-03-19T13:53:51+00:00","breadcrumb":{"@id":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.francecoag.org\/en\/publications_science\/meunier-s-et-al-use-of-clinical-practice-guidelines-on-long-term-prophylaxis-in-severe-hemophilia-in-france-a-retrospective-audit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.francecoag.org\/en\/"},{"@type":"ListItem","position":2,"name":"Publications scientifiques","item":"https:\/\/www.francecoag.org\/en\/publications_science\/"},{"@type":"ListItem","position":3,"name":"Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit"}]},{"@type":"WebSite","@id":"https:\/\/www.francecoag.org\/en\/#website","url":"https:\/\/www.francecoag.org\/en\/","name":"FranceCoag","description":"La cohorte FranceCoag accompagne plus de 10.000 patients atteints d\u2019une maladie h\u00e9morragique","publisher":{"@id":"https:\/\/www.francecoag.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.francecoag.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.francecoag.org\/en\/#organization","name":"FranceCoag","url":"https:\/\/www.francecoag.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.francecoag.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.francecoag.org\/wp-content\/uploads\/2023\/12\/logo-france-COAG-1.png","contentUrl":"https:\/\/www.francecoag.org\/wp-content\/uploads\/2023\/12\/logo-france-COAG-1.png","width":600,"height":260,"caption":"FranceCoag"},"image":{"@id":"https:\/\/www.francecoag.org\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/publications_science\/1061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/publications_science"}],"about":[{"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/types\/publications_science"}],"version-history":[{"count":1,"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/publications_science\/1061\/revisions"}],"predecessor-version":[{"id":1062,"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/publications_science\/1061\/revisions\/1062"}],"wp:attachment":[{"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/media?parent=1061"}],"wp:term":[{"taxonomy":"keyword","embeddable":true,"href":"https:\/\/www.francecoag.org\/en\/wp-json\/wp\/v2\/keyword?post=1061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}